רמיטנס 5

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

RAMIPRIL 5 MG

可用日期:

RAFA LABORATORIES LTD

ATC代码:

C09AA05

药物剂型:

CAPSULES

给药途径:

PER OS

厂商:

RAFA LABORATORIES LTD, JERUSALEM

治疗组:

RAMIPRIL

疗效迹象:

Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients suffering from impaired renal function.

授权日期:

2009-08-01